Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
about
Differentiation therapy of leukemia: 3 decades of development.Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer.SYK regulates mTOR signaling in AML.Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancerTargeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancerKnockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line.Atheroprotective pulsatile flow induces ubiquitin-proteasome-mediated degradation of programmed cell death 4 in endothelial cells.Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia.miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemiaPKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia CellsCell Density-Dependent Upregulation of PDCD4 in Keratinocytes and Its Implications for Epidermal Homeostasis and Repair.Programmed cell death 4 (PDCD4): a novel player in ethanol-mediated suppression of protein translation in primary cortical neurons and developing cerebral cortex.Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells.Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemiaTumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.miR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis.The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation.NLS‑RARα modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway.Targeting PI3K/AKT/mTOR network for treatment of leukemia.MicroRNA 200a inhibits erythroid differentiation by targeting PDCD4 and THRB.Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway.The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators.Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway.Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.Lack of Altered BECN1 Gene Expression in Iranian Patients with Acute Myeloid LeukemiaDown-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients.Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants.Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells.Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics.Biological Aspects of mTOR in Leukemia
P2860
Q33409795-C25B1F3D-BB68-4F44-86B6-3210812333D3Q33637380-CDC26FC9-EEE8-4BDE-AC4D-EEC4967643B3Q33641643-C8F0A4A9-9B08-4382-8DB8-13D6A33846D5Q34137658-1DA62F0E-DC66-4A78-8ED3-EF853095E85DQ34387697-FC940172-6C9D-494E-ABBD-26F0E80267C0Q34786163-D428B6AB-46F7-4090-AE4B-5D0BE4249E9EQ35120296-CCDE890E-FCBB-4EF6-8A81-C995FAFF659EQ35176062-0F3BE685-3633-481D-88FA-4939136F6EE6Q36100455-73570AA4-FAD9-403E-98E8-F465C08BD87BQ36422120-E32AFBD3-4814-4610-9AB6-14E08E6998E5Q36512367-51C1E756-AA81-45A0-AB78-9DE847F28D30Q37047806-B7145C4E-3F99-4F60-8C86-D3C33951DA22Q37083917-119860F1-EBE3-4020-8F04-2F94326680ADQ37249374-56C09E14-EA70-460F-8E5A-8E1B84F34A5DQ37288747-C836AFA9-DFAD-4651-AB69-AB908084728AQ37299684-C26C64C7-084D-4BC3-9835-706AB1B0BAFAQ37397092-AEAF159B-D56E-4DEE-8370-18F2B99BEA20Q37438657-FC2C0FA6-664E-4492-99EC-C46FE7A2ACF3Q37707549-FBC7EB03-7D7C-4D82-B5F5-CA732B2EA85AQ38364871-4245B646-681B-48A0-9405-7A5E158BE16AQ38741446-8C635343-8A5D-4959-B6B3-1EDC191365F3Q38923281-692F0861-47C2-43D0-8A56-F569904BEA26Q39010278-6C41EC5A-EAFA-4081-B122-B988838ED267Q39438243-4AC1EA8C-6A1C-428F-A8F4-6E2F6B92C87EQ39691093-611B868B-44F7-4F48-902C-7CDA3CD8A2B6Q39794539-AF3F4EF5-21A6-479F-B5B1-2387E2C6D49CQ42144104-C59409D7-0734-4043-8691-05721F4A7245Q43853634-7B9807A2-DA30-4F56-BACF-CCEBE9F153F5Q46874668-49D7100A-CAD6-42AC-B58D-9F09C37F02E7Q47192998-885D79C2-1837-4889-BF87-C3EBA960D095Q49628271-6BD9662B-879D-4B9B-AA6B-3EEEDFA67D39Q55260615-73073F14-7384-4BA0-9CEA-694AF5EDC625Q58780065-7243DFAB-0911-4FA5-A620-7C696A10DBF9
P2860
Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Programmed cell death-4 tumor ...... human myeloid leukemia cells.
@en
type
label
Programmed cell death-4 tumor ...... human myeloid leukemia cells.
@en
prefLabel
Programmed cell death-4 tumor ...... human myeloid leukemia cells.
@en
P2093
P1476
Programmed cell death-4 tumor ...... f human myeloid leukemia cells
@en
P2093
Bulent Ozpolat
Gabriel Lopez Berestein
Isabel Zorrilla-Calancha
Maribel Tirado-Gomez
Michael Steiner
Nancy Colburn
Steven Kornblau
P304
P356
10.1158/1541-7786.MCR-06-0125
P577
2007-01-01T00:00:00Z